VIDEO: Race to Vaccines and Therapies | Cabot Weekly Review

In today’s Weekly Video small-cap and early-stage stock analyst Tyler Laundon talks about one of the biggest trends out there – the race to bring Covid-19 vaccines and therapies to market. He highlights the bioprocessors as crucial players as the world tries to get 13 billion vaccine doses to market by the end of 2021. Stocks discussed include: TMO, DHR, RGEN.

Get It While It’s Hot!

Be among the first to see the Cabot Weekly Review when it comes out. Have it delivered right to your inbox every Saturday. Get on the list:

  • This field is for validation purposes and should be left unchanged.
Along with your weekend video, you will receive our free weekday advisory, Cabot Wealth Daily, with top stock picks, market news and insightful commentary from our analysts.
Tyler Laundon

Stocks That Can Make You RICH

Tyler Laundon is chief analyst of Cabot Small-Cap Confidential. The circulation of Small-Cap Confidential is strictly limited because the undiscovered stocks with sky-high-potential that Tyler recommends are often low-priced and thinly traded. Don’t share these recommendations!

Learn More


You must be logged in to post a comment.